Plastic waste is becoming an increasing problem, with 50 million tonnes of single-use plastic being produced each year.

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry ...

Advanced research and development of CUE-401 for IND (Investigational New Drug) readiness -CUE-401 is the Company's lead asset for the treatment of autoimmune and inflammatory diseasesAppointed indust ...

In the cases of weight loss and erectile dysfunction, more patients are getting the care they want or need. I personally ...

Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and ...

Presented in vivo and in vitro data that demonstrate the therapeutic potential of CUE-401 to restore immune balance for the ...

A drug to treat Parkinson's disease can be made from waste plastic bottles using a pioneering method, a study shows. The ...

Cambridge scientists have discovered a light-powered chemical reaction that lets researchers modify complex drug molecules at ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from ...

Organoids, assembloids, and organ-on-a-chip technologies represent transformative advances in the fields of drug discovery, precision medicine, and ...

LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 – – Reduced secured and convertible debt by 90% from $480 million to $38.8 million over 2024-2025 – – $172.1 ...

Over the past decade, however, a wave of technological advances has begun to expand the druggable proteome. These include covalent inhibitors (such as sotorasib), chemical proteomics, and AI-enabled ...